Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease
-
Published:2006-09
Issue:5
Volume:12
Page:707-735
-
ISSN:1355-6177
-
Container-title:Journal of the International Neuropsychological Society
-
language:en
-
Short-container-title:J Int Neuropsychol Soc
Author:
TWAMLEY ELIZABETH W.,ROPACKI SUSAN A. LEGENDRE,BONDI MARK W.
Abstract
Alzheimer's disease (AD) is a common, devastating form of dementia. With the advent of promising symptomatic treatment, the importance of recognizing AD at its very earliest stages has increased. We review the extant neuropsychological and neuroimaging literature on preclinical AD, focusing on longitudinal studies of initially nondemented individuals and cross-sectional investigations comparing at-risk with normal individuals. We systematically reviewed 91 studies of neuropsychological functioning, structural neuroimaging, or functional neuroimaging in preclinical AD. The neuropsychological studies indicated that preclinical AD might be characterized by subtle deficits in a broad range of neuropsychological domains, particularly in attention, learning and memory, executive functioning, processing speed, and language. Recent findings from neuroimaging research suggest that volume loss and cerebral blood flow or metabolic changes, particularly in the temporal lobe, may be detected before the onset of dementia. There exist several markers of a preclinical period of AD, in which specific cognitive and biochemical changes precede the clinical manifestations. The preclinical indicators of AD reflect early compromise of generalized brain integrity and temporal lobe functioning in particular. (JINS, 2006,12, 707–735.)
Publisher
Cambridge University Press (CUP)
Subject
Psychiatry and Mental health,Clinical Neurology,Clinical Psychology,General Neuroscience
Reference154 articles.
1. Lindsay, J. , Laurin, D. , Verreault, R. , Hébert, R. , Helliwell, B. , Hill, G.B. , & McDowell, I. (2002).Risk factors for Alzheimer's disease: A prospective analysisfrom the Canadian Study of Health and Aging.American Journal of Epidemiology,156,445–453. 2. Kawas, C. & Katzman, R. (1999).Epidemiology of dementia and Alzheimer disease. In R.D. Terry , R. Katzman , K.L. Bick , & S.S. Sisodia (Eds.),Alzheimer disease (pp.95–116).New York:Raven Press. 3. Yaffe, K. , Cauley, J. , Sands, L. , & Browner, W. (1997).Apolipoprotein E phenotype and cognitive decline in a prospectivestudy of elderly community women.Archives of Neurology,54,1110–1114. 4. Nielsen, H. , Lolk, A. , Andersen, K. , Andersen, J. , & Kragh-Sørenson, P. (1999).Characteristics of elderly who develop Alzheimer's diseaseduring the next two years: A neuropsychological study using CAMCOG. TheOdense study.International Journal of Geriatric Psychiatry,14,957–963. 5. Yoshitake, T. , Kiyohara, Y. , Kato, I. , Ohmura, T. , Iwamoto, H. , Nakayama, K. , Ohmori, S. , Nomiyama, K. , Kawaon, H. , Ueda, K. , Sueishi, K. , Tsuneyosh, M. , & Fujishima, M. (1995).Incidence and risk factors of vascular dementia and Alzheimer'sdisease in a defined elderly Japanese population: The Hisayamastudy.Neurology,45,1161–1168.
Cited by
205 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|